Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment

Key Points

• The research aims to compare the effectiveness of statins and PCSK9 inhibitors in treating coronary heart disease.
• Analyzed long-term lipid-lowering efficacy between statin and PCSK9 inhibitor therapies.
• Examined cardiovascular risk reduction as an outcome measure.
• No statistically significant difference in lipid-lowering efficacy between statins and PCSK9 inhibitors.
• Both treatments show potential for secondary prevention in coronary heart disease.